Prospective observational study of cell-free DNA as a prognostic biomarker in COVID-19 and bacterial sepsis: COVSEP-study
Katharina Hoeter, Elmo W. I. Neuberger, Vanessa Jochum, Robert Kuchen, Kira Enders, Maria Bergmann, Michael K. E. Schäfer, Perikles Simon, Marc Bodenstein · 2025
Read Prospective observational study of cell-free DNA as a prognostic biomarker in COVID-19 and bacterial sepsis: COVSEP-study by Katharina Hoeter, Elmo W. I. Neuberger, Vanessa Jochum, Robert Kuchen, Kira Enders, Maria Bergmann, Michael K. E. Schäfer, Perikles Simon, Marc Bodenstein (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12717081.txt.
Description
Katharina Hoeter and co-authors test loose DNA as a warning marker in sepsis in a 2025 study. Both COVID-19 sepsis and bacterial sepsis involve heavy inflammation and cell damage. Fragments of DNA floating free in blood mirror that damage and may forecast death. Sixty-four intensive care patients took part, split between the two sepsis kinds.
Blood DNA was measured at four time points by a standard lab method. The team weighed its link to death within thirty days and to inflammation markers. A marker that reads damage directly could sort patients by risk faster than symptom scores. Comparing the two sepsis kinds shows whether the signal is general or virus specific.
Catalog record
| CREATOR | Katharina Hoeter, Elmo W. I. Neuberger, Vanessa Jochum, Robert Kuchen, Kira Enders, Maria Bergmann, Michael K. E. Schäfer, Perikles Simon, Marc Bodenstein |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |